Loyalfordogs
Loyal (Cellular Longevity, Inc., loyalfordogs.com redirects to loyal.com) is a San Francisco biotech developing longevity drugs for dogs that target the underlying processes of aging to extend healthy lifespan in senior dogs. Its lead candidate, LOY-002, targets metabolic dysfunction in dogs aged ten and older and is progressing through FDA approval. The company serves veterinary professionals and dog owners with clinical and care resources and runs clinical trials; it publishes no developer API, documentation, SDKs, or public code repositories. Surfaced as a portfolio company of Khosla Ventures and added to the API Evangelist network.
Loyalfordogs is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Animal Health, and Veterinary.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Company 2
The organization behind the API